Patent details

EP1781705 Title: INTERFERON ALPHA RECEPTOR I ANTIBODIES AND THEIR USES

Basic Information

Publication number:
EP1781705
PCT Application Number:
PCT/US/2005/021951
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP057877433
PCT Publication Number:
WO/2006/002177
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
INTERFERON ALPHA RECEPTOR I ANTIBODIES AND THEIR USES
French Title of Invention:
ANTICORPS ANTI-RECEPTEUR AUX INTERFERONS ALPHA 1 ET LEURS UTILISATIONS
German Title of Invention:
INTERFERON-ALPHA-REZEPTOR-I-ANTIKÖRPER UND IHRE VERWENDUNG
SPC Number:

Dates

Filing date:
20/06/2005
Grant date:
08/10/2014
EP Publication Date:
08/10/2014
PCT Publication Date:
05/01/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/05/2007
EP B1 Publication Date:
08/10/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
20/06/2018
Expiration date:
20/06/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/12/2014
 
 

Name:
E. R. Squibb & Sons L.L.C.
Address:
Route 206 and Province Line Road, Princeton, NJ 08540, United States (US)

Agent

Name:
MARKS & CLERK LLP
From:
17/11/2014
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
CARDARELLI Josephine M.
Address:
United States (US)

2

Name:
SRINIVASAN Mohan
Address:
United States (US)

3

Name:
WITTE Alison
Address:
United States (US)

Priority

Priority Number:
581747 P
Priority Date:
21/06/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 16/28;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
08/06/2017
Last Annual Fee Paid Number:
13
Last Annual Fee Paid Amount:
180 Euro
Payer:
MARKS & CLERK LLP
Filing date Document type Number of pages
30/10/2018 Outgoing Correspondence 1
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56